SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-016853
Filing Date
2022-05-05
Accepted
2022-05-05 16:46:46
Documents
1
Period of Report
2022-01-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 9821
  Complete submission text file 0000899243-22-016853.txt   11385
Mailing Address 43 THORNDIKE STREET CAMBRIDGE MA 02141
Business Address 43 THORNDIKE STREET CAMBRIDGE MA 02141 617-683-0917
Amylyx Pharmaceuticals, Inc. (Issuer) CIK: 0001658551 (see all company filings)

IRS No.: 464600503 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address EERSTE WELERINGDWARSSTRAAL 54E 1017 TP AMSTERDAM P7 1017
Business Address EERSTE WELERINGDWARSSTRAAL 54E 1017 TP AMSTERDAM P7 1017 310630376119
ALS Invest 1 B.V. (Reporting) CIK: 0001920501 (see all company filings)

State of Incorp.: P7 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-41199 | Film No.: 22897229